Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07470073) titled 'A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Kinetics of Universal Car-t Cell Injection in CD19 and / or CD20 Positive Relapsed / Refractory B-cell Acute Lymphoblastic Leukemia in Adolescents, Children and Adults' on March 9.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Condition:
ALL (Acute B-Lymphoblastic Leukemia)
Intervention:
Biological: CT1190B cell injection
Recruitme...